Literature DB >> 20462384

Applied Healthspan engineering.

James W Larrick1, Andrew Mendelsohn.   

Abstract

According to the Homeric Hymn to Aphrodite, when Eos asked Zeus for Tithonus to be granted immortality, she forgot to ask for eternal youth. Applied Healthspan Engineering (AHE) seeks to address this problem. All organisms have a minimal level of functional reserve required to sustain life that eventually declines to a point incompatible with survival at death. AHE seeks to maintain or restore optimal functional reserve of critical tissues and organs. Tissue reserve correlates with well being. Diet, physical exercise, and currently available small-molecule-based therapeutics may attenuate the rate of decline of specific organs or organ systems, but are unlikely to restore lost reserve. Inherent evolutionary-derived limitations in tissue homeostasis and cell maintenance necessitate the development of therapies to enhance regenerative processes and possibly replace whole organs or tissues. AHE supports the study of cell, tissue, and organ homeostatic mechanisms to derive new regenerative and tissue replacement therapies to extend the period of human health.

Entities:  

Mesh:

Year:  2010        PMID: 20462384      PMCID: PMC2946055          DOI: 10.1089/rej.2009.0969

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  162 in total

Review 1.  Not your father's planarian: a classic model enters the era of functional genomics.

Authors:  Philip A Newmark; Alejandro Sánchez Alvarado
Journal:  Nat Rev Genet       Date:  2002-03       Impact factor: 53.242

Review 2.  Garbage catastrophe theory of aging: imperfect removal of oxidative damage?

Authors:  A Terman
Journal:  Redox Rep       Date:  2001       Impact factor: 4.412

3.  Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension.

Authors:  Marina Shargorodsky; Eyal Leibovitz; Leonid Lubimov; Dov Gavish; Reuven Zimlichman
Journal:  Am J Hypertens       Date:  2002-12       Impact factor: 2.689

4.  Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.

Authors:  T A Mori; D Q Bao; V Burke; I B Puddey; L J Beilin
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

5.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

Review 6.  Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs.

Authors:  P Palatini
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

7.  Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet.

Authors:  C Labat; P Lacolley; M Lajemi; M de Gasparo; M E Safar; A Benetos
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

8.  Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study.

Authors:  H J Schünemann; J Dorn; B J Grant; W Winkelstein; M Trevisan
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

9.  Preactivated peripheral blood monocytes in patients with essential hypertension.

Authors:  Y Dörffel; C Lätsch; B Stuhlmüller; S Schreiber; S Scholze; G R Burmester; J Scholze
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

10.  The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

Authors:  T Hayek; J Attias; R Coleman; S Brodsky; J Smith; J L Breslow; S Keidar
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

View more
  1 in total

Review 1.  You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging.

Authors:  Douglas R Seals; Rachelle E Kaplon; Rachel A Gioscia-Ryan; Thomas J LaRocca
Journal:  Physiology (Bethesda)       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.